Platelet Rich Plasma infiltration for Hip Bursitis
Phase 2
- Conditions
- Trochanteric bursitisM70.6
- Registration Number
- RBR-82gqqk
- Lead Sponsor
- Faculdade de Ciências Médicas da Santa Casa de São Paulo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Data analysis completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Twenty hips; both genders; aged eighteen to seventy nine years; more than three months of lateral hip pain; pain over the greater trochanter; painful with forced hip abduction; pain at rest; magnetic resonance imaging with diagnosis of tendinobursitis.
Exclusion Criteria
Previous hip infiltrations; intra articular hip disorders; spinal disorders; sciatic; neurological diseases associated with motor abnormalities; fibromyalgia; polyarthralgia or any other rheumatological diagnoses.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of pain (by Facial Expressions Scale for Pain) and function (by the Harris Hip Score and the Western Ontario MacMaster Score) before the procedure, after ten, thirty and sixty days.<br>It was expected an improvement in pain and function in both groups and that the PRP would be more effective than triamcinolone.;Only the corticosteroid group showed statistically significant average improvement from the pre-treatment time point to the other time points (p <0.05) for the Facial Expressions Scale for Pain and Western Ontario MacMaster Score.
- Secondary Outcome Measures
Name Time Method Evaluation of hip range of motion and strength by physical exam before the procedures.<br>Record the evolution of strength and hip movement; occurrence of infection, musculotendinous rupture and/or Trendelenburg's sign after ten, thirty and sixty days.;We had no adverse effects in this study. There were no cases of infection, musculotendinous rupture or Trendelenburg's sign.